Specialists in Gastroenterology
Low-Dose Naltrexone in Gastroenterology: A Bonafide ‘Wonder Drug’
May 03, 2024 14:31 ET | GI Alliance
St. Louis, MO, May 03, 2024 (GLOBE NEWSWIRE) -- Dr. Leonard Weinstock, a leading gastroenterologist, delves into the promising realm of low-dose naltrexone (LDN) in his recent byline article. Dr....
cmi_logo.png
[Latest] Global Cancer Cachexia Market Size/Share Worth USD 5.1 Billion by 2033 at a 5.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 03, 2024 04:30 ET | Custom Market Insights
Austin, TX, USA, May 03, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cancer Cachexia Market Size, Trends and Insights By Therapeutics (Progestogen,...
Logo.jpg
Implantable Medical Device Market To Reach USD 218.1 Billion By 2032 | DataHorizzon Research
May 03, 2024 02:40 ET | DataHorizzon Research
Fort Collins, Colorado, May 03, 2024 (GLOBE NEWSWIRE) -- The implantable medical device industry is widely driven by the rise in the prevalence of chronic diseases. The rising global prevalence...
HEALWELL-AI logo.png
WELL Launches its Second-Generation AI powered Physician Co-pilot with Chronic Disease Detection Powered by HEALWELL AI
May 02, 2024 08:00 ET | HEALWELL AI Inc.
WELL Launches its Second-Generation AI powered Physician Co-pilot with Chronic Disease Detection Powered by HEALWELL AI
Logo_Fengate w Descriptor.png
Fengate adds six seniors housing facilities to its U.S. healthcare and seniors housing portfolio
May 02, 2024 08:00 ET | Fengate Asset Management
Fengate Asset Management announces financial close on a portfolio of six seniors housing facilities in the Midwest.
Logo.jpg
Intrauterine Devices Market To Reach USD 10.5 Billion By 2032 | DataHorizzon Research
May 02, 2024 07:30 ET | DataHorizzon Research
Fort Collins, Colorado, May 02, 2024 (GLOBE NEWSWIRE) -- The growing popularity of intrauterine devices has fueled the industry's growth. A rising trend toward planned pregnancies is...
Teleflex_Global_Corporate_Brand_Logo_CMYK_Navy-White.png
Teleflex Reports First Quarter Financial Results and Full Year 2024 Outlook
May 02, 2024 06:30 ET | Teleflex Incorporated
WAYNE, Pa., May 02, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the first quarter ended March 31, 2024. First quarter...
SimpliFed and EmblemHealth are collaborating to expand access to baby feeding and breastfeeding services to EmblemHealth commercial, Medicaid, and HARP members.
SimpliFed Works with EmblemHealth to Support New Parents
May 01, 2024 08:10 ET | SimpliFed
ITHACA, NY; NEW YORK, NY, May 01, 2024 (GLOBE NEWSWIRE) -- SimpliFed, a virtual maternal health leader in lactation support, and EmblemHealth, one of the nation’s largest nonprofit health insurers,...
FTI_Logo_440x386.JPG
FTI Consulting Appoints Economics and Litigation Expert Bryan Perry as a Senior Managing Director
May 01, 2024 07:30 ET | FTI Consulting, Inc.
WASHINGTON, May 01, 2024 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of economics and litigation expert Bryan Perry as a Senior Managing Director in the...
Teleflex_Global_Corporate_Brand_Logo_CMYK_Navy-White.png
Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting
May 01, 2024 06:30 ET | Teleflex Incorporated
Highlights include two head-to-head randomized clinical trials (RCT) data presentations of UroLift™ System vs. other modalities to treat benign prostatic hyperplasia (BPH) -Additional studies examine...